Diabetes cataract study pulled before it began
NCT ID NCT04977427
First seen Mar 11, 2026 · Last updated May 02, 2026 · Updated 5 times
Summary
This study planned to compare a tiny steroid insert (Dextenza) with standard steroid eye drops for controlling inflammation after cataract surgery in people with diabetes. It aimed to see which worked better at preventing swelling and fluid buildup in the eye. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATARACT DIABETIC are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.